Tectonic Therapeutic, Inc. (TECX)
31.22
+1.28
(+4.28%)
USD |
NASDAQ |
Sep 01, 16:00
Tectonic Therapeutic Market Cap : 600.52M for Sept. 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 600.52M |
| August 31, 2026 | 575.90M |
| August 28, 2026 | 685.16M |
| August 27, 2026 | 705.93M |
| August 26, 2026 | 691.89M |
| August 25, 2026 | 725.36M |
| August 24, 2026 | 701.51M |
| August 21, 2026 | 723.82M |
| August 20, 2026 | 693.43M |
| August 19, 2026 | 712.47M |
| August 18, 2026 | 704.20M |
| August 17, 2026 | 651.11M |
| August 14, 2026 | 671.50M |
| August 13, 2026 | 653.61M |
| August 12, 2026 | 708.43M |
| August 11, 2026 | 613.03M |
| August 10, 2026 | 629.18M |
| August 07, 2026 | 595.91M |
| August 06, 2026 | 581.29M |
| August 05, 2026 | 568.59M |
| August 04, 2026 | 546.59M |
| August 03, 2026 | 523.17M |
| July 31, 2026 | 525.23M |
| July 30, 2026 | 534.23M |
| July 29, 2026 | 532.73M |
| Date | Value |
|---|---|
| July 28, 2026 | 558.40M |
| July 27, 2026 | 573.58M |
| July 24, 2026 | 569.08M |
| July 23, 2026 | 592.31M |
| July 22, 2026 | 591.94M |
| July 21, 2026 | 614.61M |
| July 20, 2026 | 600.93M |
| July 17, 2026 | 610.87M |
| July 16, 2026 | 574.33M |
| July 15, 2026 | 608.99M |
| July 14, 2026 | 652.28M |
| July 13, 2026 | 643.47M |
| July 10, 2026 | 644.03M |
| July 09, 2026 | 660.90M |
| July 08, 2026 | 664.83M |
| July 07, 2026 | 684.60M |
| July 06, 2026 | 659.96M |
| July 02, 2026 | 710.74M |
| July 01, 2026 | 613.49M |
| June 30, 2026 | 644.13M |
| June 29, 2026 | 620.05M |
| June 26, 2026 | 599.44M |
| June 25, 2026 | 581.45M |
| June 24, 2026 | 575.64M |
| June 23, 2026 | 573.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.088B |
| Alnylam Pharmaceuticals, Inc. | 33.96B |
| Anika Therapeutics, Inc. | 281.18M |
| Savara, Inc. | 1.128B |
| Vericel Corp. | 2.087B |
Market Cap Related Metrics
| PEG Ratio | -0.5228 |
| Price to Book Value | 2.683 |
| Price | 31.22 |
| Earnings Yield | -14.62% |
| PEGY Ratio | -0.5228 |